Molecular design and biological activities of NF-κB inhibitors

Molecules and Cells

Volumn 14, Issue 2, 2002, Pages 163-167

  Umezawa, Kazuo ^a   Chaicharoenpong, Chanya ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Apoptosis; COS 1 Cells; DHMEQ; Jurkat Cells; NF B; Nuclear Transport; TNF

Indexed keywords

DEHYDROXYMETHYL EPOXYQUINOMICIN; EPOXIDE; EPOXYQUINOMICIN C; I KAPPA B; SMAD2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; CYCLOHEXANONE DERIVATIVE; DEHYDROXYMETHYLEPOXYQUINOMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CELL NUCLEUS TRANSPLANTATION; DNA BINDING; LEUKEMIA CELL LINE; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; T CELL LEUKEMIA; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BENZAMIDES; CYCLOHEXANONES; DRUG DESIGN; HUMANS; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 0037206564     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (32)

1. Aggarwal, B. B. (2000) Tumor necrosis factor receptor-associated signaling molecules and their role in activation of apoptosis, JNK and NF-κB. Ann. Rheum. Dis. 59 Suppl. 6-16.
2. Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789.
3. Ariga, A., Namekawa, J., Matsumoto, N., Inoue, J., and Umezawa, K. (2002) Inhibition of TNF-α-induced nuclear translocation and activation of NF-κB by dehydroxymethyl-epoxyquinomicin. J. Biol. Chem. 277, 24625-24630.
4. Baeuerle, P. A. (1998) IκB-NF-κB structures: at the interface of inflammation control. Cell 95, 729-731.
5. Baeuerle, P. A. and Baltimore, D. (1996) NF-κB: ten years after. Cell 87, 13-20.
6. Baeuerle, P. A. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
7. Baldwin, A. S. Jr. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
8. Beg, A. A. and Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
9. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
10. Cleveland, J. L. and Ihle, J. N. (1995) Contenders in FasL/TNF death signaling. Cell 81, 479-482.
11. Erkel, G., Anke, T., and Sterner, O. (1996) Inhibition of NF-κB activation by panepoxydone. Biochem. Biophys. Res. Commun. 226, 214-221.
12. Gehrt, A., Erkel, G., Anke, T., and Sterner, O. (1998) Cyclo-epoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3- pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction. J. Antibiot. 51, 455-463.
13. Hsu, H., Xiong, J., and Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
14. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
15. Israël, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. (1989) TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8, 3793-3800.
16. Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K. F., Izpisua-Belmonte, J. C., and Verma, I. M. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1332-1328.
17. Matsumoto, N., Tsuchida, T., Umekita, M., Kinoshita, N., Iimuma, H., Sawa, T., Hamada, M., and Takeuchi, T. (1997a) Epoxyquinomicins A, B, C, and D, new antibiotics from Amycolatopsis. I. Taxonomy, fermentation, isolation, and antimicrobial activities. J. Antibiot. 50, 900-905.
18. Matsumoto, N., Iimuma, H., Sawa, T., and Takeuchi, T. (1997b) Epoxyquinomicins A, B, C, and D, new antibiotics from Amycolatopsis. II. Effect on type II collagen-induced arthritis in mice. J. Antibiot. 50, 906-911.
19. Matsumoto, N., Ariga, A., To-e, S., Nakamura, H., Agata, N., Hirano, S., Inoue, J., and Umezawa, K. (2000) Synthesis of NF-ê activation inhibitors derived from epoxyquinomicin C. Bioorg. Med. Chem. Lett. 10, 865-869.
20. May, M. J., D'Acquisto, F., Madge, L. A., Glockner, J., Pober, J. S., and Ghosh, S. (2000) Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289, 1550-1554.
21. Old, L. J. (1985) Tumor necrosis factor (TNF). Science 230, 630-632.
22. Osborn, L., Kunkel, S., and Nabel, G. J. (1989) Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86, 2336-2340.
23. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., and Donner, D. B. (1999) NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
24. Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T.; Warring, P., Mühlbacher, A., Czernilofsky, A. P., and Baeuerle P. A. (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med., 183, 1829-1840.
25. Romashkova, J. A. and Makarov, S. S. (1999) NF-κB is a target of Akt in antiapoptotic PDGF signaling. Nature 401, 86-90.
26. Rothe, J., Gehr, G., Loetscher, H., and Lesslauer, W. (1992) Tumor necrosis factor receptors-structure and function. Immunol. Res. 11, 81-90.
27. Sen, R. and Baltimore, D. (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.
28. Shoji, S., Furuishi, K., Ogata, A., Yamataka, K., Tachibana, K., Mukai, R., Uda, A., Harano, K., Matsushita, S., and Misumi, S. (1998) An allosteric drug, O,O′-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-κB. Biochem. Biophys. Res. Commun. 249, 745-753.
29. Tartaglia, L. A. and Goeddel, D. V. (1992) Two TNF receptors. Immunol. Today 13, 151-153.
30. Wang, C. Y., Mayo, M. W., and Baldwin, Jr. A. S. (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
31. Yuasa, T., Ohno, S., Kehrl, J. H., and Kyriakis, J. M. (1998) Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273, 22681-22692.
32. Xia, D., Wang, F., and Parmely, M. J. (2000) Inhibition of nuclear factor-kappa B activation in mouse macrophages and the RAW 264.7 cell line by a synthetic adenyl carbocyclic nucleoside. Biochem. Phamacol. 60, 717-727.